Top

Published in:

01-08-2021 | Artificial Intelligence | Special Section: HCC Treatment

Artificial intelligence in assessment of hepatocellular carcinoma treatment response

Authors: Bradley Spieler, Carl Sabottke, Ahmed W. Moawad, Ahmed M. Gabr, Mustafa R. Bashir, Richard Kinh Gian Do, Vahid Yaghmai, Radu Rozenberg, Marielia Gerena, Joseph Yacoub, Khaled M. Elsayes

Published in: Abdominal Radiology | Issue 8/2021

Abstract

Artificial Intelligence (AI) continues to shape the practice of radiology, with imaging of hepatocellular carcinoma (HCC) being of no exception. This article prepared by members of the LI-RADS Treatment Response (TR LI-RADS) work group and associates, presents recent trends in the utility of AI applications for the volumetric evaluation and assessment of HCC treatment response. Various topics including radiomics, prognostic imaging findings, and locoregional therapy (LRT) specific issues will be discussed in the framework of HCC treatment response classification systems with focus on the Liver Reporting and Data System treatment response algorithm (LI-RADS TRA).

Kielar A, Fowler KJ, Lewis S, et al. (2018) Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY) 43(1):218–230. https://doi.org/10.1007/s00261-017-1281-6CrossRef

Shropshire EL, Chaudhry M, Miller CM, et al. (2019) LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy. Radiology 292(1):226–234. https://doi.org/10.1148/radiol.2019182135CrossRefPubMed

Abdel Razek AAK, El-Serougy LG, Saleh GA, Shabana W, Abd El-Wahab R (2020) Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy. Diagn Interv Imaging 101(9):547–553. https://doi.org/10.1016/j.diii.2020.03.008CrossRefPubMed

Liew C (2018) The future of radiology augmented with Artificial Intelligence: A strategy for success. Eur J Radiol 102:152–156. https://doi.org/10.1016/j.ejrad.2018.03.019CrossRefPubMed

Hardy M, Harvey H (2019) Artificial intelligence in diagnostic imaging: impact on the radiography profession. The British Journal of Radiology 93(1108):20190840. https://doi.org/10.1259/bjr.20190840CrossRefPubMed

Kulkarni S, Seneviratne N, Baig MS, Khan AHA (2020) Artificial Intelligence in Medicine: Where Are We Now? Academic Radiology 27(1):62–70. https://doi.org/10.1016/j.acra.2019.10.001CrossRefPubMed

Zhou LQ, Wang JY, Yu SY, et al. (2019) Artificial intelligence in medical imaging of the liver. World J Gastroenterol 25(6):672–682. https://doi.org/10.3748/wjg.v25.i6.672CrossRefPubMedPubMedCentral

Pérez MJ, Grande RG (2020) Application of artificial intelligence in the diagnosis and treatment of hepatocellular carcinoma: A review. World Journal of Gastroenterology 26(37):5617–5628CrossRef

Dong Y, Zhou L, Xia W, Zhao X-Y, Zhang Q, Jian J-M, Gao X, Wang W-P (2020) Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: Initial Application of a Radiomic Algorithm Based on Grayscale Ultrasound Images. Frontiers in Oncology 10 (353). https://doi.org/10.3389/fonc.2020.00353

10.

Liu D, Liu F, Xie X, et al. (2020) Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound. Eur Radiol 30(4):2365–2376. https://doi.org/10.1007/s00330-019-06553-6CrossRefPubMed

11.

Akai H, Yasaka K, Kunimatsu A, et al. (2018) Predicting prognosis of resected hepatocellular carcinoma by radiomics analysis with random survival forest. Diagn Interv Imaging 99(10):643–651. https://doi.org/10.1016/j.diii.2018.05.008CrossRefPubMed

12.

Do S, Song KD, Chung JW (2020) Basics of Deep Learning: A Radiologist’s Guide to Understanding Published Radiology Articles on Deep Learning. Korean J Radiol 21(1):33–41. https://doi.org/10.3348/kjr.2019.0312CrossRefPubMed

13.

Nakaura T, Higaki T, Awai K, Ikeda O, Yamashita Y (2020) A primer for understanding radiology articles about machine learning and deep learning. Diagn Interv Imaging 101(12):765–770. https://doi.org/10.1016/j.diii.2020.10.001CrossRefPubMed

14.

Ibrahim SM, Nikolaidis P, Miller FH, et al. (2009) Radiologic findings following Y90 radioembolization for primary liver malignancies. Abdom Imaging 34(5):566–581. https://doi.org/10.1007/s00261-008-9454-yCrossRefPubMed

15.

Joo I, Kim HC, Kim GM, Paeng JC (2018) Imaging Evaluation Following (90)Y Radioembolization of Liver Tumors: What Radiologists Should Know. Korean J Radiol 19(2):209–222. https://doi.org/10.3348/kjr.2018.19.2.209CrossRefPubMedPubMedCentral

16.

Riaz A, Kulik L, Lewandowski RJ, et al. (2009) Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 49(4):1185–1193. https://doi.org/10.1002/hep.22747CrossRefPubMed

17.

Abajian A, Murali N, Savic LJ, et al. (2018) Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept. J Vasc Interv Radiol 29(6):850–857.e851. https://doi.org/10.1016/j.jvir.2018.01.769CrossRefPubMedPubMedCentral

18.

Morshid A, Elsayes KM, Khalaf AM, Elmohr MM, Yu J, Kaseb AO, Hassan M, Mahvash A, Wang Z, Hazle JD, Fuentes D (2019) A machine learning model to predict hepatocellular carcinoma response to transcatheter arterial chemoembolization. Radiol Artif Intell 1 (5). https://doi.org/10.1148/ryai.2019180021

19.

Peng J, Kang S, Ning Z, et al. (2020) Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging. Eur Radiol 30(1):413–424. https://doi.org/10.1007/s00330-019-06318-1CrossRefPubMed

20.

Wu CF, Wu YJ, Liang PC, et al. (2017) Disease-free survival assessment by artificial neural networks for hepatocellular carcinoma patients after radiofrequency ablation. J Formos Med Assoc 116(10):765–773. https://doi.org/10.1016/j.jfma.2016.12.006CrossRefPubMed

21.

Yu SJ, Kim H, Min H, et al. (2017) Targeted Proteomics Predicts a Sustained Complete-Response after Transarterial Chemoembolization and Clinical Outcomes in Patients with Hepatocellular Carcinoma: A Prospective Cohort Study. J Proteome Res 16(3):1239–1248. https://doi.org/10.1021/acs.jproteome.6b00833CrossRefPubMed

22.

Sohn JH, Duran R, Zhao Y, et al. (2017) Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy. Clin Gastroenterol Hepatol 15(5):746–755.e744. https://doi.org/10.1016/j.cgh.2016.10.036CrossRefPubMed

23.

Yau T, Tang VY, Yao TJ, et al. (2014) Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology 146(7):1691–1700.e1693. https://doi.org/10.1053/j.gastro.2014.02.032CrossRefPubMed

24.

Longo L, Rodrigues de Freitas LB, Santos D, Grivicich I, Alvares-da-Silva MR (2019) BCLC-B Subclassification and the Hong Kong Liver Cancer System in Intermediate Hepatocellular Carcinoma: Identifying Candidates for Curative Therapy. Am J Clin Oncol 42(5):466–471. https://doi.org/10.1097/coc.0000000000000539CrossRefPubMed

25.

Lambin P, Rios-Velazquez E, Leijenaar R, et al. (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48(4):441–446. https://doi.org/10.1016/j.ejca.2011.11.036CrossRefPubMedPubMedCentral

26.

AI Challenge. (2019). https://www.rsna.org/en/education/ai-resources-and-training/ai-image-challenge. Accessed November 3, 2020

27.

Bilic P, Christ P, Vorontsov E, Chlebus G, Chen H, Dou Q, Fu C-W, Han X, Heng P, Hesser J, Kadoury S, Konopczynski TK, Le M, Li C, Li X, Lipková J, Lowengrub J, Meine H, Moltz J, Pal C, Piraud M, Qi X, Qi J, Rempfler M, Roth K, Schenk A, Sekuboyina A, Zhou P, Hülsemeyer C, Beetz M, Ettlinger F, Grün F, Kaissis G, Lohöfer F, Braren R, Holch J, Hofmann F, Sommer W, Heinemann V, Jacobs C, Mamani G, Ginneken B, Chartrand G, Tang A, Drozdzal M, Ben-Cohen A, Klang E, Amitai M, Konen E, Greenspan H, Moreau J, Hostettler A, Soler L, Vivanti R, Szeskin A, Lev-Cohain N, Sosna J, Joskowicz L, Menze B (2019) The Liver Tumor Segmentation Benchmark (LiTS). ArXiv abs/1901.04056

28.

Grewal M, Srivastava MM, Kumar P, Varadarajan S (2018) RADnet: Radiologist level accuracy using deep learning for hemorrhage detection in CT scans. 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018):281-284

29.

Ding Y, Sohn JH, Kawczynski MG, et al. (2019) A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using (18)F-FDG PET of the Brain. Radiology 290(2):456–464. https://doi.org/10.1148/radiol.2018180958CrossRefPubMed

30.

Çiçek Ö, Abdulkadir A, Lienkamp S, Brox T, Ronneberger O 3D U-Net: Learning Dense Volumetric Segmentation from Sparse Annotation. In: MICCAI, 2016.

31.

Lee K, Zung J, Li P, Jain V, Seung HS (2017) Superhuman Accuracy on the SNEMI3D Connectomics Challenge. ArXiv abs/1706.00120

32.

Ronneberger O, Fischer P, Brox T U-Net: Convolutional Networks for Biomedical Image Segmentation. In, Cham, 2015. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015. Springer International Publishing, pp 234-241

33.

Angermann C, Haltmeier M Random 2.5D U-net for Fully 3D Segmentation. In, Cham, 2019. Machine Learning and Medical Engineering for Cardiovascular Health and Intravascular Imaging and Computer Assisted Stenting. Springer International Publishing, pp 158-166

34.

Meine H, Chlebus G, Ghafoorian M, Endo I, Schenk A (2018) Comparison of U-net-based Convolutional Neural Networks for Liver Segmentation in CT. ArXiv abs/1810.04017

35.

Taha AA, Hanbury A (2015) Metrics for evaluating 3D medical image segmentation: analysis, selection, and tool. BMC Med Imaging 15:29–29. https://doi.org/10.1186/s12880-015-0068-xCrossRefPubMedPubMedCentral

36.

Wang K, Mamidipalli A, Retson T, et al. (2019) Automated CT and MRI Liver Segmentation and Biometry Using a Generalized Convolutional Neural Network. Radiology: Artificial Intelligence 1(2): https://doi.org/10.1148/ryai.2019180022CrossRefPubMedPubMedCentral

37.

Lu F, Wu F, Hu P, Peng Z, Kong D (2016) Automatic 3D liver location and segmentation via convolutional neural network and graph cut. International Journal of Computer Assisted Radiology and Surgery 12:171–182CrossRefPubMed

38.

Zheng Y, Ai D, Mu J, et al. (2017) Automatic liver segmentation based on appearance and context information. Biomed Eng Online 16(1):16. https://doi.org/10.1186/s12938-016-0296-5CrossRefPubMedPubMedCentral

39.

Ibragimov B, Toesca D, Chang D, Koong A, Xing L (2017) Combining deep learning with anatomical analysis for segmentation of the portal vein for liver SBRT planning. Phys Med Biol 62(23):8943–8958. https://doi.org/10.1088/1361-6560/aa9262CrossRefPubMedPubMedCentral

40.

Vorontsov E, Cerny M, Régnier P, et al. (2019) Deep Learning for Automated Segmentation of Liver Lesions at CT in Patients with Colorectal Cancer Liver Metastases. Radiology: Artificial Intelligence 1(2): https://doi.org/10.1148/ryai.2019180014CrossRefPubMedPubMedCentral

41.

Christ PF, Elshaer MEA, Ettlinger F, et al. (2016) Automatic Liver and Lesion Segmentation in CT Using Cascaded Fully Convolutional Neural Networks and 3D Conditional Random Fields. In: Ourselin S, Joskowicz L, Sabuncu MR, Unal G, Wells W (eds) Medical Image Computing and Computer-Assisted Intervention – MICCAI 2016. Cham: Springer International Publishing, pp 415–423CrossRef

42.

Vivanti R, Joskowicz L, Lev-Cohain N, Ephrat A, Sosna J (2018) Patient-specific and global convolutional neural networks for robust automatic liver tumor delineation in follow-up CT studies. Med Biol Eng Comput 56(9):1699–1713. https://doi.org/10.1007/s11517-018-1803-6CrossRefPubMed

43.

Sun C, Guo S, Zhang H, et al. (2017) Automatic segmentation of liver tumors from multiphase contrast-enhanced CT images based on FCNs. Artif Intell Med 83:58–66. https://doi.org/10.1016/j.artmed.2017.03.008CrossRefPubMed

44.

Ben-Cohen A, Diamant I, Klang E, Amitai M, Greenspan H Fully Convolutional Network for Liver Segmentation and Lesions Detection. In, Cham, 2016. Deep Learning and Data Labeling for Medical Applications. Springer International Publishing, pp 77-85

45.

Vivanti R, Szeskin A, Lev-Cohain N, Sosna J, Joskowicz L (2017) Automatic detection of new tumors and tumor burden evaluation in longitudinal liver CT scan studies. International Journal of Computer Assisted Radiology and Surgery 12:1945–1957CrossRefPubMed

46.

Vivanti R, Joskowicz L, Lev-Cohain N, Ephrat A, Sosna J (2018) Patient-specific and global convolutional neural networks for robust automatic liver tumor delineation in follow-up CT studies. Medical & Biological Engineering & Computing 56:1699–1713CrossRef

47.

Park S, Chu LC, Fishman EK, et al. (2020) Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation. Diagn Interv Imaging 101(1):35–44. https://doi.org/10.1016/j.diii.2019.05.008CrossRefPubMed

48.

Joskowicz L, Cohen D, Caplan N, Sosna J (2019) Inter-observer variability of manual contour delineation of structures in CT. Eur Radiol 29(3):1391–1399. https://doi.org/10.1007/s00330-018-5695-5CrossRefPubMed

49.

Xu Z, Burke RP, Lee CP, et al. (2015) Efficient multi-atlas abdominal segmentation on clinically acquired CT with SIMPLE context learning. Med Image Anal 24(1):18–27. https://doi.org/10.1016/j.media.2015.05.009CrossRefPubMedPubMedCentral

50.

Shimizu A, Ohno R, Ikegami T, et al. (2007) Segmentation of multiple organs in non-contrast 3D abdominal CT images. International Journal of Computer Assisted Radiology and Surgery 2(3):135–142. https://doi.org/10.1007/s11548-007-0135-zCrossRef

51.

Wolz R, Chu C, Misawa K, Mori K, Rueckert D (2012) Multi-organ abdominal CT segmentation using hierarchically weighted subject-specific atlases. Med Image Comput Comput Assist Interv 15(Pt 1):10–17. https://doi.org/10.1007/978-3-642-33415-3_2CrossRefPubMed

52.

Linguraru MG, Sandberg JK, Li Z, Pura JA, Summers RM (2009) Atlas-based Automated Segmentation of Spleen and Liver using Adaptive Enhancement Estimation. Med Image Comput Comput Assist Interv 5762:1001–1008. https://doi.org/10.1007/978-3-642-04271-3_121CrossRefPubMedPubMedCentral

53.

Zhang X, Tian J, Deng K, Wu Y, Li X (2010) Automatic liver segmentation using a statistical shape model with optimal surface detection. IEEE Trans Biomed Eng 57(10):2622–2626. https://doi.org/10.1109/tbme.2010.2056369CrossRefPubMed

54.

Wang X, Zheng Y, Gan L, et al. (2017) Liver segmentation from CT images using a sparse priori statistical shape model (SP-SSM). PLoS One 12(10): https://doi.org/10.1371/journal.pone.0185249CrossRefPubMedPubMedCentral

55.

Spinczyk D, Krasoń A (2018) Automatic liver segmentation in computed tomography using general-purpose shape modeling methods. Biomed Eng Online 17(1):65. https://doi.org/10.1186/s12938-018-0504-6CrossRefPubMedPubMedCentral

56.

Zheng B-H, Liu L-Z, Zhang Z-Z, et al. (2018) Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients. BMC Cancer 18(1):1148. https://doi.org/10.1186/s12885-018-5024-zCrossRefPubMedPubMedCentral

57.

Reiner CS, Gordic S, Puippe G, et al. (2016) Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment. Cardiovasc Intervent Radiol 39(3):400–408. https://doi.org/10.1007/s00270-015-1185-1CrossRefPubMed

58.

Fedorov A, Beichel R, Kalpathy-Cramer J, et al. (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 30(9):1323–1341. https://doi.org/10.1016/j.mri.2012.05.001CrossRefPubMedPubMedCentral

59.

Yushkevich PA, Piven J, Hazlett HC, et al. (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31(3):1116–1128. https://doi.org/10.1016/j.neuroimage.2006.01.015CrossRefPubMed

60.

van Griethuysen JJM, Fedorov A, Parmar C, et al. (2017) Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 77(21):e104–e107. https://doi.org/10.1158/0008-5472.Can-17-0339CrossRefPubMedPubMedCentral

61.

Zhang L, Fried DV, Fave XJ, et al. (2015) IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. Med Phys 42(3):1341–1353. https://doi.org/10.1118/1.4908210CrossRefPubMedPubMedCentral

62.

Rizzo S, Botta F, Raimondi S, et al. (2018) Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp 2(1):36. https://doi.org/10.1186/s41747-018-0068-zCrossRefPubMedPubMedCentral

63.

Miranda Magalhaes Santos JM, Clemente Oliveira B, Araujo-Filho JAB, et al. (2020) State-of-the-art in radiomics of hepatocellular carcinoma: a review of basic principles, applications, and limitations. Abdom Radiol (NY) 45(2):342–353. https://doi.org/10.1007/s00261-019-02299-3CrossRef

64.

Larkin TJ, Canuto HC, Kettunen MI, et al. (2014) Analysis of image heterogeneity using 2D Minkowski functionals detects tumor responses to treatment. Magn Reson Med 71(1):402–410. https://doi.org/10.1002/mrm.24644CrossRefPubMed

65.

Hui TCH, Chuah TK, Low HM, Tan CH (2018) Predicting early recurrence of hepatocellular carcinoma with texture analysis of preoperative MRI: a radiomics study. Clin Radiol 73(12):1056.e1011–1056.e1016. https://doi.org/10.1016/j.crad.2018.07.109CrossRef

66.

Zhang Z, Jiang H, Chen J, et al. (2019) Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction. Cancer Imaging 19(1):22. https://doi.org/10.1186/s40644-019-0209-5CrossRefPubMedPubMedCentral

67.

Park YK, Song SK, Kim BW, et al. (2017) Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma. World J Surg Oncol 15(1):225. https://doi.org/10.1186/s12957-017-1292-3CrossRefPubMedPubMedCentral

68.

Lim KC, Chow PK, Allen JC, et al. (2011) Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg 254(1):108–113. https://doi.org/10.1097/SLA.0b013e31821ad884CrossRefPubMed

69.

Ni M, Zhou X, Lv Q, et al. (2019) Radiomics models for diagnosing microvascular invasion in hepatocellular carcinoma: which model is the best model? Cancer Imaging 19(1):60. https://doi.org/10.1186/s40644-019-0249-xCrossRefPubMedPubMedCentral

70.

He M, Zhang P, Ma X, et al. (2020) Radiomic Feature-Based Predictive Model for Microvascular Invasion in Patients With Hepatocellular Carcinoma. Front Oncol 10: https://doi.org/10.3389/fonc.2020.574228CrossRefPubMedPubMedCentral

71.

Xu X, Zhang HL, Liu QP, et al. (2019) Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol 70(6):1133–1144. https://doi.org/10.1016/j.jhep.2019.02.023CrossRefPubMed

72.

Banerjee S, Wang DS, Kim HJ, et al. (2015) A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology 62(3):792–800. https://doi.org/10.1002/hep.27877CrossRefPubMed

73.

Peng J, Zhang J, Zhang Q, et al. (2018) A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma. Diagn Interv Radiol 24(3):121–127. https://doi.org/10.5152/dir.2018.17467CrossRefPubMedPubMedCentral

74.

Soltaninejad M, Yang G, Lambrou T, et al. (2017) Automated brain tumour detection and segmentation using superpixel-based extremely randomized trees in FLAIR MRI. Int J Comput Assist Radiol Surg 12(2):183–203. https://doi.org/10.1007/s11548-016-1483-3CrossRefPubMed

75.

van Heeswijk MM, Lambregts DM, van Griethuysen JJ, et al. (2016) Automated and Semiautomated Segmentation of Rectal Tumor Volumes on Diffusion-Weighted MRI: Can It Replace Manual Volumetry? Int J Radiat Oncol Biol Phys 94(4):824–831. https://doi.org/10.1016/j.ijrobp.2015.12.017CrossRefPubMed

76.

Odland A, Server A, Saxhaug C, et al. (2015) Volumetric glioma quantification: comparison of manual and semi-automatic tumor segmentation for the quantification of tumor growth. Acta Radiol 56(11):1396–1403. https://doi.org/10.1177/0284185114554822CrossRefPubMed

77.

Hopper KD, Kasales CJ, Van Slyke MA, et al. (1996) Analysis of interobserver and intraobserver variability in CT tumor measurements. American Journal of Roentgenology 167(4):851–854. https://doi.org/10.2214/ajr.167.4.8819370CrossRefPubMed

78.

Sohaib SA, Turner B, Hanson JA, et al. (2000) CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol 73(875):1178–1184. https://doi.org/10.1259/bjr.73.875.11144795CrossRefPubMed

79.

Zhou Z, Xue-chang Z, Si-ming Z, Hua-fei X, Yue-ding S (2018) Semi-automatic Liver Segmentation in CT Images Through Intensity Separation and Region Growing. Procedia Computer Science 131:220–225. https://doi.org/10.1016/j.procs.2018.04.206CrossRef

80.

Ma J, Li Y, Wu Y, Zhang M, He J, Qiu Y, Yang X Automatic Liver Tumor Segmentation Based on Random Forest and Fuzzy Clustering. In, Cham, 2019. The Proceedings of the International Conference on Sensing and Imaging. Springer International Publishing, pp 403-410

81.

Yu Q, Shi Y, Sun J, et al. (2019) Crossbar-Net: A Novel Convolutional Neural Network for Kidney Tumor Segmentation in CT Images. IEEE Transactions on Image Processing 28(8):4060–4074. https://doi.org/10.1109/TIP.2019.2905537CrossRef

82.

Li X, Chen H, Qi X, et al. (2018) H-DenseUNet: Hybrid Densely Connected UNet for Liver and Tumor Segmentation From CT Volumes. IEEE Trans Med Imaging 37(12):2663–2674. https://doi.org/10.1109/tmi.2018.2845918CrossRefPubMed

83.

Tacher V, Lin M, Duran R, et al. (2016) Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach. Radiology 278(1):275–284. https://doi.org/10.1148/radiol.2015142951CrossRefPubMed

84.

Moawad A, Fuentes D, Khalaf A, et al. (2020) Feasibility of Automated Volumetric Assessment of Large Hepatocellular Carcinomas’ Responses to Transarterial Chemoembolization. Frontiers in Oncology 10:572. https://doi.org/10.3389/fonc.2020.00572CrossRefPubMedPubMedCentral

Title: Artificial intelligence in assessment of hepatocellular carcinoma treatment response
Authors: Bradley Spieler
Carl Sabottke
Ahmed W. Moawad
Ahmed M. Gabr
Mustafa R. Bashir
Richard Kinh Gian Do
Vahid Yaghmai
Radu Rozenberg
Marielia Gerena
Joseph Yacoub
Khaled M. Elsayes
Publication date: 01-08-2021
Publisher: Springer US
Keywords: Artificial Intelligence
Hepatocellular Carcinoma
Hepatocellular Carcinoma
Published in: Abdominal Radiology / Issue 8/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-021-03056-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2021

Preoperative evaluation of extramural venous invasion in rectal cancer using radiomics analysis of relaxation maps from synthetic MRI

Radiomics of hepatocellular carcinoma: promising roles in patient selection, prediction, and assessment of treatment response

Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: a retrospective controlled study

Role of the radiologist at HCC multidisciplinary conference and use of the LR-TR algorithm for improving workflow

CT reporting of relevant vascular variations and its implication in pancreatoduodenectomy

Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage